APPLICATION
ANDA088379
TYPE
ANDA
ORIGINAL APPROVAL
1983-11-16
LATEST ACTION
2010-12-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
THIORIDAZINE HYDROCHLORIDEDiscontinued
THIORIDAZINE HYDROCHLORIDE 100MG · TABLET · ORAL
Approval history
2010-12-03Labeling · Supplement 26AP
1998-12-01Manufacturing (CMC) · Supplement 25AP
1994-12-23Manufacturing (CMC) · Supplement 24AP
1994-10-11Manufacturing (CMC) · Supplement 23AP
1992-05-01Manufacturing (CMC) · Supplement 15AP
1992-04-03Manufacturing (CMC) · Supplement 22AP
1992-04-03Manufacturing (CMC) · Supplement 20AP
1990-06-12Bioequivalence · Supplement 19AP
1990-02-23Labeling · Supplement 17AP
1988-06-02Labeling · Supplement 13AP
1988-03-03Manufacturing (CMC) · Supplement 11AP
1987-03-31Manufacturing (CMC) · Supplement 9AP
1986-02-11Manufacturing (CMC) · Supplement 8AP
1986-02-11Manufacturing (CMC) · Supplement 6AP
1986-02-11Manufacturing (CMC) · Supplement 7AP
1986-02-11Manufacturing (CMC) · Supplement 5AP
1983-11-16OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.